Found "Public health policy": 1,056 results
Combating a Global Public Health Threat: Antimicrobial Resistance – What are we doing?
Antimicrobial resistance (AMR) is one of the most pressing public health challenges worldwide. It occurs when antimicrobials—such as antibiotics, antifungals, antivirals, and antiparasitics—become ineffective against microorganisms like bacteria, fungi, viruses, and parasites. This resistance can le
Early Career Path: Reflection from the Infectious Disease Modelling (IDM) Conference 2024
I would like to express my gratitude for the opportunity and the support from the UNITE initiative under the Program Management Unit for Human Resources & Institutional Development, Research and Innovation (PMU-B) to be part of the panel discussion at the “Early Career Path” session during the I
Implementing Health Tech for UHC: Real-World Lessons from PMAC 2025
The rapid advancement of technology is reshaping global health, offering new opportunities to strengthen health systems. The Prince Mahidol Award Conference (PMAC) 2025, under the theme of “Harnessing Technologies in an Age of AI to Build a Healthier World,” provided invaluable insights into the com
Is AI the Answer? Exploring the Challenges and Solutions of AI in Strengthening Health Systems: Insights from PMAC 2025
At the recent Prince Mahidol Award Conference (PMAC) 2025, the Health Intervention and Technology Assessment Program (HITAP) Foundation hosted a side meeting on the role of artificial intelligence (AI) in healthcare. This meeting “Is AI a Panacea for the Health Sector? Navigating the Barriers to Ado
Overcoming Barriers: Financing and Service Delivery for Vaccination in Fragile and Conflict-Affected States
Vaccination is a critical and cost-effective public health intervention that significantly reduces child mortality. Since the inception of the World Health Organization’s Expanded Program on Immunization (WHO-EPI) in 1974, vaccines have saved millions of lives, with a Lancet study highlighting that
A feasibility study of allogeneic hematopoietic stem cell transplantation for severe thalassemic patients covered by Universal Coverage scheme
The Cost-utility analysis (CUA) study of Hematopoietic stem cell transplantation (HSCT) versus blood transfusion and iron chelating therapy (standard treatment) found that related HSCT (sibling donor) is more cost effective than unrelated HSCT in patients ≤ 10 years old in Thai healthcare setting. However, there currently has capacity limit for H
Rise in UK drug-resistant tuberculosis cases
Cases of drug-resistant tuberculosis (TB) in the UK have risen by over a quarter in the last year, the Health Protection Agency (HPA) has revealed.In 2011, 431 cases did not respond to antibiotic treatment compared to 342 in 2010, the HPA said. About 550 more cases of TB were disgnosed in 2011.The a
OxyContin abuse down with time-release formula
(Reuters Health) – There’s more evidence that the new formulation of OxyContin, the time-release version of oxycodone, is discouraging abuse of the powerful drug.But the reformulation, introduced in August 2010 to make it harder to crush the medicine into powder, limiting the ability to snort, injec
California county wants drug makers to pay for pill disposal
(Reuters) – Pharmaceutical companies selling drugs in parts of the San Francisco Bay area would be required to submit plans for incinerating or safely disposing of unused medication under a plan advanced by county officials this week.The measure, billed by supporters as the first of its kind in the
Alzheimer’s ‘early signs timeline developed’
Scientists have assembled a “timeline” of the unseen progress of Alzheimer’s before symptoms appear.A team at Washington University School of Medicine looked at families with a genetic risk of the disease.Writing in the New England Journal of Medicine, they say signs appeared up to 25 years before t
10 / Page